dc.creator | Dardiotis E., Siokas V., Aloizou A.-M., Karampinis E., Brotis A.G., Grigoriadis S., Paterakis K., Dardioti M., Komnos A., Kapsalaki E., Fountas K., Hadjigeorgiou G.M. | en |
dc.date.accessioned | 2023-01-31T07:50:58Z | |
dc.date.available | 2023-01-31T07:50:58Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.1080/02699052.2019.1606444 | |
dc.identifier.issn | 02699052 | |
dc.identifier.uri | http://hdl.handle.net/11615/73092 | |
dc.description.abstract | Background: Α few genetic variants are associated with the outcome after traumatic brain injury (TBI). Integrins are glycoprotein receptors that play an important role in the integrity of microvasculature of the brain. Objective: To examine the role of integrin-AV (ITGAV) and integrin-B8 (ITGB8) tag single nucleotide polymorphisms (SNPs) on the outcome of patients with TBI. Methods: 363 participants were included and genotyped for 11 SNPs for ITGAV and 11 for ITGB8 gene. SNPs were tested for associations with the 6-month outcome after TBI, the presence of a hemorrhagic event after TBI, and the initial TBI severity after adjustment for TBI’s main predictors. Results: The ITGAV rs3911239 CC and rs7596996 GG genotypes were associated with an unfavorable outcome after TBI, compared to the TT and AA genotypes, respectively. The ITGB8 rs10239099 CC and rs3757727 CC genotypes were associated with increased risk of any cerebral hemorrhagic event after TBI compared to GG and TT respectively. The ITGAV rs7589470 and rs7565633 were associated with the TBI’s initial severity. Conclusions: ITGAV gene SNPs may be implicated in the outcome after TBI, as well as in the initial TBI severity, and also of ITGB8 gene SNPs in the risk of hemorrhagic event after a TBI. © 2019, © 2019 Taylor & Francis Group, LLC. | en |
dc.language.iso | en | en |
dc.source | Brain Injury | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065185506&doi=10.1080%2f02699052.2019.1606444&partnerID=40&md5=a1fa23a01cba841eef6fafcbc242488c | |
dc.subject | integrin | en |
dc.subject | beta integrin | en |
dc.subject | CD51 antigen | en |
dc.subject | integrin beta8 | en |
dc.subject | adult | en |
dc.subject | allele | en |
dc.subject | Article | en |
dc.subject | association | en |
dc.subject | brain hemorrhage | en |
dc.subject | clinical outcome | en |
dc.subject | cohort analysis | en |
dc.subject | disease severity | en |
dc.subject | DNA polymorphism | en |
dc.subject | female | en |
dc.subject | genotype | en |
dc.subject | heterozygosity | en |
dc.subject | homozygosity | en |
dc.subject | human | en |
dc.subject | major clinical study | en |
dc.subject | male | en |
dc.subject | mutational load | en |
dc.subject | regression analysis | en |
dc.subject | single nucleotide polymorphism | en |
dc.subject | traumatic brain injury | en |
dc.subject | x-ray computed tomography | en |
dc.subject | adolescent | en |
dc.subject | aged | en |
dc.subject | brain hemorrhage | en |
dc.subject | complication | en |
dc.subject | genetics | en |
dc.subject | genotype | en |
dc.subject | middle aged | en |
dc.subject | single nucleotide polymorphism | en |
dc.subject | traumatic brain injury | en |
dc.subject | very elderly | en |
dc.subject | young adult | en |
dc.subject | Adolescent | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Aged, 80 and over | en |
dc.subject | Brain Injuries, Traumatic | en |
dc.subject | Cerebral Hemorrhage | en |
dc.subject | Female | en |
dc.subject | Genotype | en |
dc.subject | Humans | en |
dc.subject | Integrin alphaV | en |
dc.subject | Integrin beta Chains | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Polymorphism, Single Nucleotide | en |
dc.subject | Young Adult | en |
dc.subject | Taylor and Francis Ltd | en |
dc.title | Effect of integrin AV and B8 gene polymorphisms in patients with traumatic brain injury | en |
dc.type | journalArticle | en |